Results

Total Results: 33 records

Showing results for "author year description".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
    February 01, 2018 - Version 1.0 September 2017 Disclaimer The findings and conclusions in this document are those of the author … Using This Artifact ............................................................................ 2 Description … Implementing and Using This Artifact Description and Purpose of the Artifact This artifact provides … Table 1: Artifact Manifest Filename Purpose Author(s) Million_Hearts_Baseli CQL representation of … ASCVD Risk 8 Version 1.0 September 2017 Filename Purpose Author(s) Million_Hearts_Baseli ne_10_
  2. cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
    December 01, 2018 - The findings and conclusions in this document are those of the author … This was a “lessons learned” from the pilot partnership last year with a health center affiliate … Implementation Decision: Change code to specify a 1-year lookback. … Application for new terminology codes (at least using the LOINC terminology), requires IP approval from the author … LOINC representatives are willing to assist with author engagement to facilitate approval.
  3. cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - ........................................................................................ 3 Artifact Description … Implementing and Using This Artifact Artifact Description The Aspirin Therapy artifact helps clinicians … Patient has less than a 10-year life expectancy. h. … can use the open-source Clinical Quality Language Visual Studio Code extension to more efficiently author … Contents Figures Tables Background Introduction Implementing and Using This Artifact Artifact Description
  4. cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - ........................................................................................ 3 Artifact Description … Implementing and Using This Artifact Artifact Description This artifact provides statin therapy recommendations … would be 75 – 76 during the current calendar year. … Implementation guidance Clarify difference between eCQM narrative and eCQM logic The narrative description … Contents Figures Tables Background Introduction Implementing and Using This Artifact Artifact Description
  5. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - ....................................................................................... 9 Artifact Description … Implementing and Using This Artifact Artifact Description This CDS artifact provides the ability … cql-execution https://github.com/DBCG/cql_engine 15 Table 1: Artifact Manifest Filename Purpose Author … Rute Martins, Chris Moesel, Sharon Sebastian 16 Filename Purpose Author(s) CDS_Connect_Conve … Purpose, and Audience of This Implementation Guide Implementing and Using This Artifact Artifact Description
  6. cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
    January 01, 2010 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk (April … ........................................................................................ 9 Artifact Description … Implementing and Using This Artifact Artifact Description The Updated ASCVD Risk artifact extends … Calculation of a baseline 10-Year ASCVD risk assessment score. 2. … Purpose, and Audience of This Implementation Guide Implementing and Using This Artifact Artifact Description
  7. cds.ahrq.gov/sites/default/files/workgroups/28166/CDS_Connect_WG_Slides_August%202021.pdf
    August 01, 2021 - 15 Testing FAIRness: Example Example: A FAIR guiding principle applied to develop a criterion, description … of the criterion, and scoring element Criteria # Criteria Description Scoring F1.1.1 Artifacts have … in progress): − CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year
  8. cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - Updated10- year ASCVD risk score calculation to use either of two ACC- endorsed risk scores. … ........................................................................................ 4 Artifact Description … Implementing and Using This Artifact Artifact Description This artifact identifies adults aged 40 … risk of CVD events.2 The ACC/AHA PCE calculates the 10-year risk of an atherosclerotic CVD (ASCVD) … Tables Background Introduction Scope and Purpose Implementing and Using This Artifact Artifact Description
  9. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - Updated10- year ASCVD risk score calculation to use either of two ACC- endorsed risk scores. … ........................................................................................ 4 Artifact Description … Implementing and Using This Artifact Artifact Description This artifact identifies adults aged 40 … risk of CVD events.”2 The ACC/AHA PCE calculates the 10-year risk of an atherosclerotic CVD (ASCVD) … Tables Background Introduction Scope and Purpose Implementing and Using This Artifact Artifact Description
  10. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - ........................................................................................ 4 Artifact Description … Implementing and Using This Artifact Artifact Description This artifact identifies adults aged 40 … risk of CVD events.”2 The ACC/AHA PCE calculates the 10-year risk of an atherosclerotic CVD (ASCVD) … The second difference is the recommendation for offering a statin when the 10-year CVD risk is 7.5% … Tables Background Introduction Scope and Purpose Implementing and Using This Artifact Artifact Description
  11. cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
    April 01, 2021 - ........................................................................................ 9 Artifact Description … Implementing and Using This Artifact Artifact Description This artifact extends the use of the CMS … Calculation of a baseline 10-Year ASCVD risk assessment score. 2. … “10-year risk” Risk of showing evidence of ASCVD within the next 10 years. … Purpose, and Audience of This Implementation Guide Implementing and Using This Artifact Artifact Description
  12. cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
    January 01, 2024 - ........................................................................................ 4 Artifact Description … Implementing and Using This Artifact Artifact Description This artifact identifies adult patients … The author of the CQL may not proceed to writing or updating the next portion of the code until all … Inclusions “estimated 10-year ASCVD risk of 7.5% or greater” The estimated 10-year ASCVD risk score … Tables Background Introduction Scope and Purpose Implementing and Using This Artifact Artifact Description
  13. cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
    January 01, 2021 - Then for each field, the definition includes characteristics such as the title or caption, the description … For example, an author can choose a code-based property and indicate a set of codes it should match … As another example, an author could choose a quantity-based property and indicate a range it should … In Figure 5, an author has defined a query representing the following: CDS Connect Maintenance … For each link, the author must provide a label, a type (“absolute” or “smart”), and a URL.
  14. cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
    January 01, 2024 - ........................................................................................ 4 Artifact Description … glucose level consistent with prediabetes. 4 Implementing and Using This Artifact Artifact Description … Bravo is a 22-year-old overweight Hispanic woman with a family history of diabetes. … The author of the CQL may not proceed to writing or updating the next portion of the code until all … • Synthetic patient included because they are a 28-year-old Asian female with a BMI of 23 kg/m2.
  15. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
    January 01, 2024 - ........................................................................................ 4 Artifact Description … Implementing and Using This Artifact Artifact Description This artifact identifies patients in relevant … Bravo is a 28-year-old woman who developed gestational diabetes during her last pregnancy. … Individuals who had behavioral counseling for nutrition and/or activity within the past year. … The author of the CQL may not proceed to writing or updating the next portion of the code until all
  16. cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible … Introduction 1 Background 1 Audience, Purpose, and Scope of this IG 1 Implementing and Using This Artifact 2 Description … Implementing and Using This Artifact Description and Purpose of the Artifact This artifact provides the … Calculation of a baseline 10-Year ASCVD risk assessment score. 2. … "10-year... risk" Risk of showing evidence of ASCVD within the next 10 years.
  17. cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
    January 01, 2024 - Implementing and Using This Artifact Description and Purpose of the Artifact This artifact allows … The author of the CQL may not proceed to writing or updating the next portion of the code until all … In 2024, the artifact author elected to remove ICD-9 codes (which had been used to capture historic … The lookback period is expressed as one year to align with the recommendation. … The CQL queries for the result of all assessments completed in the past year.
  18. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible … Introduction 1 Background 1 Audience, Purpose, and Scope of this IG 1 Implementing and Using This Artifact 2 Description … Implementing and Using This Artifact Description and Purpose of the Artifact This artifact helps providers … Data-driven screening, when a new 10-year ASCVD risk score is documented Ms. … Patient has less than 10-year life expectancy. h.
  19. cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible … Introduction 1 Background 1 Audience, Purpose, and Scope of this IG 1 Implementing and Using This Artifact 2 Description … Implementing and Using This Artifact Description and Purpose of the Artifact This artifact extends the … artifact “Longitudinal ASCVD Tool for Baseline 10-Year ASCVD Risk.” … Calculation of a baseline 10-Year ASCVD risk assessment score. 2.
  20. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - Version 1.0 September 2017 Disclaimer The findings and conclusions in this document are those of the author … Introduction 1 Background 1 Audience, Purpose, and Scope of this IG 1 Implementing and Using This Artifact 2 Description … Implementing and Using This Artifact Description and Purpose of the artifact This artifact provides statin … Table 1: Artifact Manifest Filename Purpose Author(s) Statin_Therapy_for_the_Prevention_and_Treatment_of_CVD_eCQM_Derived_FHIRv102 … would be 75-76 during the current calendar year.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: